Steven Cohen’s Cardiol Therapeutics CRDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.89M Buy
1,740,891
+1,722,537
+9,385% +$2.74M ﹤0.01% 2193
2026
Q2
$19.5K Buy
+18,354
New +$23.2K ﹤0.01% 3877

Other funds holding CRDL

Steven Cohen's CRDL Position: Q3 2026 in Review

Steven Cohen increased its Cardiol Therapeutics (CRDL) stake by 9,385% in Q3 2026, buying an estimated $2.74M and bringing the position to 1,740,891 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2193.

Steven Cohen first reported a position in CRDL in Q2 2026 and has held it in 2 quarters since. 59 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.

  • Steven Cohen held 1,740,891 shares of Cardiol Therapeutics worth $2.89M as of Q3 2026.
  • Steven Cohen bought 1,722,537 Cardiol Therapeutics shares in Q3 2026, an estimated $2.74M.
  • Cardiol Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2193 holding.
  • Steven Cohen first reported a position in Cardiol Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 59 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.